Franzosini achieves GDP ISO certification
a new milestone in pharmaceutical logistics
Franzosini SA has obtained GDP certification – Good Distribution Practice for Medicinal Products, issued by SQS – Swiss Association for Quality and Management Systems, thus adding a new and important recognition to its quality management system. This certification, which complies with European Union guidelines (2013/C 343/01), attests that the company operates according to the standards required for the safe and controlled distribution of medicinal products for human use, in compliance with technical, regulatory and organizational criteria of the highest level.
Obtaining GDP certification represents a strategic milestone that strengthens Franzosini’s position in the pharmaceutical logistics and sensitive goods distribution sector, consolidating its role as a qualified partner for companies in the healthcare, pharmaceutical and para-pharmaceutical sectors, in Switzerland and internationally.
A rigorous and responsible adjustment path
The certification process required a thorough review of operating procedures, with special attention to the transportation and storage phases of medicines. Franzosini introduced advanced measures for the control of environmental conditions, continuous monitoring of the cold chain, periodic staff training, supplier qualification and complete traceability of logistics flows. Each activity has been documented and audited by SQS independent experts.
The company has equipped itself with environmental control tools in the warehouses and means of transportation to ensure that each shipment is made in compliance with the conditions required for the storage of sensitive products. The implemented management system also provides for constant risk assessment, continuous process improvement, and the adoption of compliance criteria in line with the highest international standards.
Compliant, ethical and public health-oriented logistics
For Franzosini, GDP certification represents not only compliance with a regulatory requirement, but the assumption of a concrete responsibility to public health. The distribution of medical products cannot ignore quality, traceability, reliability and rigor. In this context, the company has chosen to structure its logistics offering according to the principles of operational integrity, document transparency and process security.
Obtaining certification from SQS not only confirms the soundness of existing practices, but also opens up new perspectives for the expansion of services aimed at the pharma & healthcare sector, enabling the management of complex logistics flows in compliance with current regulations and market expectations.
A certification that strengthens corporate identity
With the entry of GDP certification, Franzosini further integrates its quality system, already structured around ISO 9001 (quality), ISO 14001 (environment) and ISO 27001 (information security) certifications. The focus on regulatory compliance and certified quality is an integral part of the company culture, which is based on processes that are measurable, verifiable and inspired by continuous improvement.
Franzosini considers pharmaceutical logistics a strategic function, requiring specialized skills, ethical sensitivity and solid infrastructure. Obtaining GDP certification is therefore a concrete recognition of the company’s ability to operate in regulated and highly critical areas, actively contributing to supply chain security in the healthcare sector.
https://www.franzosini.ch/wp-content/uploads/2025/06/116345_it_H61336.pdf
